Warning sounded over waits for cancer treatment in Quebec

April 16, 2001

Although there is currently no agreement on what the optimal time to treatment should be, practice guidelines for breast cancer emphasize that the work-up of a lump in the breast should be completed as soon as possible after detection.

To assess the time interval from diagnosis to surgery, Dr. Nancy Mayo and colleagues examined physician fee-for-service claims and hospital admissions for all Quebec women who underwent an invasive procedure for the diagnosis or treatment of breast cancer between 1993 and 1998.

The authors found a significant increase over the 6-year period in waiting time between initial diagnosis and first surgery. The number of episodes of breast cancer surgery rose from 3626 in 1992 to 5162 in 1998, and the median waiting time rose from 29 days to 42 days respectively. The proportion of episodes in which women underwent 3 or more diagnostic procedures before surgery increased from 19.2% in 1992 to 33.0% in 1998, and as the number of procedures increased, so did the wait.

"At this time, the data from our study provide information on expected delays and serve to warn us that rapid cuts in health care spending, if they are not accompanied by an effective planning process, may produce undesirable effects in service delivery," the authors conclude.
-end-
Journalists' note: This is the first article to receive "fast-track" status from CMAJ. Under this process, editorial review of articles, including peer review, is speeded up so that important results can be reported more quickly. An explanation of the process is provided in an editorial appearing in this issue.

Waiting time for breast cancer surgery in Quebec

-- N.E. Mayo et., al.

Contact: Dr. Nancy Mayo, Division of Clinical Epidemiology, Royal Victoria Hospital, Montreal; tel: 514-842-1231 x6906

Canadian Medical Association Journal

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.